Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 72 entries
Sorted by: Best Match Show Resources per page
Medical vs surgical management of left main coronary artery disease.

JAMA

Modest GA.
PMID: 15741526
JAMA. 2005 Mar 02;293(9):1060-1; author reply 1061. doi: 10.1001/jama.293.9.1060-b.

No abstract available.

Cite
Modest GA. Medical vs surgical management of left main coronary artery disease. JAMA. 2005;293(9):1060-1; author reply 1061doi: 10.1001/jama.293.9.1060-b.
Modest, G. A. (2005). Medical vs surgical management of left main coronary artery disease. JAMA, 293(9), 1060-1; author reply 1061. https://doi.org/10.1001/jama.293.9.1060-b
Modest, Geoffrey A. "Medical vs surgical management of left main coronary artery disease." JAMA vol. 293,9 (2005): 1060-1; author reply 1061. doi: https://doi.org/10.1001/jama.293.9.1060-b
Modest GA. Medical vs surgical management of left main coronary artery disease. JAMA. 2005 Mar 02;293(9):1060-1; author reply 1061. doi: 10.1001/jama.293.9.1060-b. PMID: 15741526.
Copy Download .nbib Format: NLM
A new aggressive approach to screening and early intervention to prevent death from coronary artery disease.

MedGenMed : Medscape general medicine

Lundberg GD.
PMID: 17406162
MedGenMed. 2006 Jul 31;8(3):22.

No abstract available.

Cite
Lundberg GD. A new aggressive approach to screening and early intervention to prevent death from coronary artery disease. MedGenMed. 2006;8(3):22
Lundberg, G. D. (2006). A new aggressive approach to screening and early intervention to prevent death from coronary artery disease. MedGenMed : Medscape general medicine, 8(3), 22.
Lundberg, George D. "A new aggressive approach to screening and early intervention to prevent death from coronary artery disease." MedGenMed : Medscape general medicine vol. 8,3 (2006): 22.
Lundberg GD. A new aggressive approach to screening and early intervention to prevent death from coronary artery disease. MedGenMed. 2006 Jul 31;8(3):22. PMID: 17406162; PMCID: PMC1781258.
Copy Download .nbib Format: NLM
Bibliography-editors' selection of current world literature.

Coronary artery disease

[No authors listed]
PMID: 22481221
Coron Artery Dis. 2012 May;23(3):223-5. doi: 10.1097/MCA.0b013e3283536372.

No abstract available.

Cite
Bibliography-editors' selection of current world literature. Coron Artery Dis. 2012;23(3):223-5doi: 10.1097/MCA.0b013e3283536372.
(2012). Bibliography-editors' selection of current world literature. Coronary artery disease, 23(3), 223-5. https://doi.org/10.1097/MCA.0b013e3283536372
"Bibliography-editors' selection of current world literature." Coronary artery disease vol. 23,3 (2012): 223-5. doi: https://doi.org/10.1097/MCA.0b013e3283536372
Bibliography-editors' selection of current world literature. Coron Artery Dis. 2012 May;23(3):223-5. doi: 10.1097/MCA.0b013e3283536372. PMID: 22481221.
Copy Download .nbib Format: NLM
Does a hybrid approach to multivessel revascularisation really make sense?.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Taggart DP.
PMID: 23538151
EuroIntervention. 2013 Mar;8(11):1231-3. doi: 10.4244/EIJV8I11A189.

No abstract available.

Cite
Taggart DP. Does a hybrid approach to multivessel revascularisation really make sense?. EuroIntervention. 2013;8(11):1231-3doi: 10.4244/EIJV8I11A189.
Taggart, D. P. (2013). Does a hybrid approach to multivessel revascularisation really make sense?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 8(11), 1231-3. https://doi.org/10.4244/EIJV8I11A189
Taggart, David P. "Does a hybrid approach to multivessel revascularisation really make sense?." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 8,11 (2013): 1231-3. doi: https://doi.org/10.4244/EIJV8I11A189
Taggart DP. Does a hybrid approach to multivessel revascularisation really make sense?. EuroIntervention. 2013 Mar;8(11):1231-3. doi: 10.4244/EIJV8I11A189. PMID: 23538151.
Copy Download .nbib Format: NLM
About the use of DES (drug-eluting stents) in real life: the importance of registries.

Arquivos brasileiros de cardiologia

Negreiros de Andrade PJ.
PMID: 21603798
Arq Bras Cardiol. 2011 May;96(5):425; author reply 425-6. doi: 10.1590/s0066-782x2011005000025.

No abstract available.

Cite
Negreiros de Andrade PJ. About the use of DES (drug-eluting stents) in real life: the importance of registries. Arq Bras Cardiol. 2011;96(5):425; author reply 425-6doi: 10.1590/s0066-782x2011005000025.
Negreiros de Andrade, P. J. (2011). About the use of DES (drug-eluting stents) in real life: the importance of registries. Arquivos brasileiros de cardiologia, 96(5), 425; author reply 425-6. https://doi.org/10.1590/s0066-782x2011005000025
Negreiros de Andrade, Pedro José. "About the use of DES (drug-eluting stents) in real life: the importance of registries." Arquivos brasileiros de cardiologia vol. 96,5 (2011): 425; author reply 425-6. doi: https://doi.org/10.1590/s0066-782x2011005000025
Negreiros de Andrade PJ. About the use of DES (drug-eluting stents) in real life: the importance of registries. Arq Bras Cardiol. 2011 May;96(5):425; author reply 425-6. doi: 10.1590/s0066-782x2011005000025. Portuguese, Spanish. PMID: 21603798.
Copy Download .nbib Format: NLM
Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents.

Expert review of cardiovascular therapy

Roh JH, Kim YH.
PMID: 26563909
Expert Rev Cardiovasc Ther. 2016;14(2):229-43. doi: 10.1586/14779072.2016.1120158. Epub 2015 Dec 29.

Current evidence and guidelines support the use of the single-stent technique as the default treatment strategy for the treatment of coronary bifurcations. For the single-stent technique, routine final kissing balloon inflation is not recommended, unless side branch ostial stenosis...

Cite
Roh JH, Kim YH. Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents. Expert Rev Cardiovasc Ther. 2015;14(2):229-43doi: 10.1586/14779072.2016.1120158.
Roh, J. H., & Kim, Y. H. (2016). Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents. Expert review of cardiovascular therapy, 14(2), 229-43. https://doi.org/10.1586/14779072.2016.1120158
Roh, Jae-Hyung, and Kim, Young-Hak. "Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents." Expert review of cardiovascular therapy vol. 14,2 (2016): 229-43. doi: https://doi.org/10.1586/14779072.2016.1120158
Roh JH, Kim YH. Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents. Expert Rev Cardiovasc Ther. 2016;14(2):229-43. doi: 10.1586/14779072.2016.1120158. Epub 2015 Dec 29. PMID: 26563909.
Copy Download .nbib Format: NLM
Drug-eluting stent outcomes in diabetes.

Expert review of cardiovascular therapy

Bernelli C, Chan J, Chieffo A.
PMID: 24345095
Expert Rev Cardiovasc Ther. 2014 Jan;12(1):95-109. doi: 10.1586/14779072.2014.853615. Epub 2013 Dec 18.

Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of...

Cite
Bernelli C, Chan J, Chieffo A. Drug-eluting stent outcomes in diabetes. Expert Rev Cardiovasc Ther. 2013;12(1):95-109doi: 10.1586/14779072.2014.853615.
Bernelli, C., Chan, J., & Chieffo, A. (2014). Drug-eluting stent outcomes in diabetes. Expert review of cardiovascular therapy, 12(1), 95-109. https://doi.org/10.1586/14779072.2014.853615
Bernelli, Chiara, et al. "Drug-eluting stent outcomes in diabetes." Expert review of cardiovascular therapy vol. 12,1 (2014): 95-109. doi: https://doi.org/10.1586/14779072.2014.853615
Bernelli C, Chan J, Chieffo A. Drug-eluting stent outcomes in diabetes. Expert Rev Cardiovasc Ther. 2014 Jan;12(1):95-109. doi: 10.1586/14779072.2014.853615. Epub 2013 Dec 18. PMID: 24345095.
Copy Download .nbib Format: NLM
Plaque characterization in unstable versus stable diabetics: insights illuminated by OCT.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Hanson ID, Goldstein JA.
PMID: 25322711
Catheter Cardiovasc Interv. 2014 Nov 01;84(5):708-9. doi: 10.1002/ccd.25655.

No abstract available.

Cite
Hanson ID, Goldstein JA. Plaque characterization in unstable versus stable diabetics: insights illuminated by OCT. Catheter Cardiovasc Interv. 2014;84(5):708-9doi: 10.1002/ccd.25655.
Hanson, I. D., & Goldstein, J. A. (2014). Plaque characterization in unstable versus stable diabetics: insights illuminated by OCT. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 84(5), 708-9. https://doi.org/10.1002/ccd.25655
Hanson, Ivan D, and Goldstein, James A. "Plaque characterization in unstable versus stable diabetics: insights illuminated by OCT." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 84,5 (2014): 708-9. doi: https://doi.org/10.1002/ccd.25655
Hanson ID, Goldstein JA. Plaque characterization in unstable versus stable diabetics: insights illuminated by OCT. Catheter Cardiovasc Interv. 2014 Nov 01;84(5):708-9. doi: 10.1002/ccd.25655. PMID: 25322711.
Copy Download .nbib Format: NLM
The conundrum of coronary revascularization: stent or bypass.

The Journal of thoracic and cardiovascular surgery

Deb S, Fremes SE.
PMID: 25500292
J Thorac Cardiovasc Surg. 2015 Mar;149(3):839-40. doi: 10.1016/j.jtcvs.2014.11.027. Epub 2014 Nov 20.

No abstract available.

Cite
Deb S, Fremes SE. The conundrum of coronary revascularization: stent or bypass. J Thorac Cardiovasc Surg. 2014;149(3):839-40doi: 10.1016/j.jtcvs.2014.11.027.
Deb, S., & Fremes, S. E. (2015). The conundrum of coronary revascularization: stent or bypass. The Journal of thoracic and cardiovascular surgery, 149(3), 839-40. https://doi.org/10.1016/j.jtcvs.2014.11.027
Deb, Saswata, and Fremes, Stephen E. "The conundrum of coronary revascularization: stent or bypass." The Journal of thoracic and cardiovascular surgery vol. 149,3 (2015): 839-40. doi: https://doi.org/10.1016/j.jtcvs.2014.11.027
Deb S, Fremes SE. The conundrum of coronary revascularization: stent or bypass. J Thorac Cardiovasc Surg. 2015 Mar;149(3):839-40. doi: 10.1016/j.jtcvs.2014.11.027. Epub 2014 Nov 20. PMID: 25500292.
Copy Download .nbib Format: NLM
Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.

Atherosclerosis

Zdanyte M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, Gawaz M, Geisler T, Rath D.
PMID: 33341519
Atherosclerosis. 2021 Feb;318:1-7. doi: 10.1016/j.atherosclerosis.2020.12.007. Epub 2020 Dec 13.

BACKGROUND AND AIMS: Thromboischemic and bleeding events are rare but life-threatening complications after percutaneous coronary intervention (PCI). Various risk assessment models have been established to predict short- and long-term adverse events in patients with chronic and acute coronary syndromes...

Cite
Zdanyte M, Wrazidlo RW, Kaltenbach S, et al. Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores. Atherosclerosis. 2020;318:1-7doi: 10.1016/j.atherosclerosis.2020.12.007.
Zdanyte, M., Wrazidlo, R. W., Kaltenbach, S., Groga-Bada, P., Gawaz, M., Geisler, T., & Rath, D. (2021). Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores. Atherosclerosis, 3181-7. https://doi.org/10.1016/j.atherosclerosis.2020.12.007
Zdanyte, Monika, et al. "Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores." Atherosclerosis vol. 318 (2021): 1-7. doi: https://doi.org/10.1016/j.atherosclerosis.2020.12.007
Zdanyte M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, Gawaz M, Geisler T, Rath D. Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores. Atherosclerosis. 2021 Feb;318:1-7. doi: 10.1016/j.atherosclerosis.2020.12.007. Epub 2020 Dec 13. PMID: 33341519.
Copy Download .nbib Format: NLM
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease.

Cardiology clinics

Moscarella E, Gragnano F, Cesaro A, Ielasi A, Diana V, Conte M, Schiavo A, Coletta S, Di Maio D, Fimiani F, Calabrò P.
PMID: 33036719
Cardiol Clin. 2020 Nov;38(4):575-588. doi: 10.1016/j.ccl.2020.07.003.

Functionally significant coronary lesions identification is necessary for appropriate revascularization. This review aims to provide an overview of the available options for coronary stenosis physiologic evaluation with a focus on the latest developments in the field.

Cite
Moscarella E, Gragnano F, Cesaro A, et al. Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease. Cardiol Clin. 2020;38(4):575-588doi: 10.1016/j.ccl.2020.07.003.
Moscarella, E., Gragnano, F., Cesaro, A., Ielasi, A., Diana, V., Conte, M., Schiavo, A., Coletta, S., Di Maio, D., Fimiani, F., & Calabrò, P. (2020). Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease. Cardiology clinics, 38(4), 575-588. https://doi.org/10.1016/j.ccl.2020.07.003
Moscarella, Elisabetta, et al. "Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease." Cardiology clinics vol. 38,4 (2020): 575-588. doi: https://doi.org/10.1016/j.ccl.2020.07.003
Moscarella E, Gragnano F, Cesaro A, Ielasi A, Diana V, Conte M, Schiavo A, Coletta S, Di Maio D, Fimiani F, Calabrò P. Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease. Cardiol Clin. 2020 Nov;38(4):575-588. doi: 10.1016/j.ccl.2020.07.003. PMID: 33036719.
Copy Download .nbib Format: NLM
Non-invasive vulnerable plaque imaging: how do we know that treatment works?.

European heart journal. Cardiovascular Imaging

Sannino A, Brevetti L, Giugliano G, Scudiero F, Toscano E, Mainolfi C, Cuocolo A, Perrino C, Stabile E, Trimarco B, Esposito G.
PMID: 24876097
Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1194-202. doi: 10.1093/ehjci/jeu097. Epub 2014 May 29.

Atherosclerosis is an inflammatory disorder that can evolve into an acute clinical event by plaque development, rupture, and thrombosis. Plaque vulnerability represents the susceptibility of a plaque to rupture and to result in an acute cardiovascular event. Nevertheless, plaque...

Cite
Sannino A, Brevetti L, Giugliano G, et al. Non-invasive vulnerable plaque imaging: how do we know that treatment works?. Eur Heart J Cardiovasc Imaging. 2014;15(11):1194-202doi: 10.1093/ehjci/jeu097.
Sannino, A., Brevetti, L., Giugliano, G., Scudiero, F., Toscano, E., Mainolfi, C., Cuocolo, A., Perrino, C., Stabile, E., Trimarco, B., & Esposito, G. (2014). Non-invasive vulnerable plaque imaging: how do we know that treatment works?. European heart journal. Cardiovascular Imaging, 15(11), 1194-202. https://doi.org/10.1093/ehjci/jeu097
Sannino, Anna, et al. "Non-invasive vulnerable plaque imaging: how do we know that treatment works?." European heart journal. Cardiovascular Imaging vol. 15,11 (2014): 1194-202. doi: https://doi.org/10.1093/ehjci/jeu097
Sannino A, Brevetti L, Giugliano G, Scudiero F, Toscano E, Mainolfi C, Cuocolo A, Perrino C, Stabile E, Trimarco B, Esposito G. Non-invasive vulnerable plaque imaging: how do we know that treatment works?. Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1194-202. doi: 10.1093/ehjci/jeu097. Epub 2014 May 29. PMID: 24876097.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 72 entries